Sinopharm Group Co. Ltd. - Depositary Receipt (Common Stock) - Laporan Laba Rugi (TTM)

Sinopharm Group Co. Ltd. - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US82937K1016
€ 10.10 ↑0.15 (1.51%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Sinopharm Group Co. Ltd. - Depositary Receipt (Common Stock) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 440,194 456,415 474,798 501,770 510,090 521,051 528,383 533,403 546,147 552,148 570,067 591,626 591,686 596,570 598,318 590,346 590,267 584,508 578,904 575,824
Change (%) 3.68 4.03 5.68 1.66 2.15 1.41 0.95 2.39 1.10 3.25 3.78 0.01 0.83 0.29 -1.33 -0.01 -0.98 -0.96 -0.53
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 401,128 416,091 433,877 458,102 466,055 477,001 483,541 488,282 500,522 504,714 521,703 542,579 543,101 548,058 550,171 542,839 543,530 540,252 535,341 533,060
Change (%) 3.73 4.27 5.58 1.74 2.35 1.37 0.98 2.51 0.84 3.37 4.00 0.10 0.91 0.39 -1.33 0.13 -0.60 -0.91 -0.43
% of Revenue 91.13 91.17 91.38 91.30 91.37 91.55 91.51 91.54 91.65 91.41 91.52 91.71 91.79 91.87 91.95 91.95 92.08 92.43 92.48 92.57
Gross Operating Profit 39,067 40,323 40,921 43,669 44,035 44,051 44,842 45,121 45,625 47,434 48,365 49,047 48,585 48,512 48,146 47,507 46,737 44,255 43,563 42,764
Change (%) 3.22 1.48 6.71 0.84 0.04 1.80 0.62 1.12 3.96 1.96 1.41 -0.94 -0.15 -0.75 -1.33 -1.62 -5.31 -1.57 -1.83
% of Revenue 8.87 8.83 8.62 8.70 8.63 8.45 8.49 8.46 8.35 8.59 8.48 8.29 8.21 8.13 8.05 8.05 7.92 7.57 7.53 7.43
SG&A 21,135 21,873 22,643 23,652 24,049 23,656 23,884 24,276 24,584 25,346 25,995 26,657 26,639 26,775 26,981 26,418 26,989 26,905 26,441 26,078
Change (%) 3.49 3.52 4.46 1.68 -1.63 0.97 1.64 1.27 3.10 2.56 2.55 -0.07 0.51 0.77 -2.09 2.16 -0.31 -1.72 -1.37
% of Revenue 4.80 4.79 4.77 4.71 4.71 4.54 4.52 4.55 4.50 4.59 4.56 4.51 4.50 4.49 4.51 4.47 4.57 4.60 4.57 4.53
R&D 0 42 29 19 84 34 50 -25 131 -130 -8 -7
Change (%) -626.56 -199.48 -6.37
% of Revenue 0.00 0.01 0.01 0.00 0.02 0.01 0.01 -0.00 0.02 -0.02 -0.00 -0.00
OpEx 421,721 437,312 456,273 481,176 489,668 500,068 506,853 511,979 524,658 529,383 547,049 568,542 569,184 574,251 576,627 569,606 569,527 566,689 561,304 558,559
Change (%) 3.70 4.34 5.46 1.76 2.12 1.36 1.01 2.48 0.90 3.34 3.93 0.11 0.89 0.41 -1.22 -0.01 -0.50 -0.95 -0.49
% of Revenue 95.80 95.81 96.10 95.90 96.00 95.97 95.93 95.98 96.07 95.88 95.96 96.10 96.20 96.26 96.37 96.49 96.49 96.95 96.96 97.00
Operating Income 18,474 19,102 18,525 20,594 20,423 20,984 21,530 21,424 21,489 22,764 23,019 23,085 22,502 22,318 21,690 20,740 20,740 17,819 17,600 17,265
Change (%) 3.40 -3.02 11.17 -0.83 2.75 2.60 -0.49 0.30 5.94 1.12 0.29 -2.52 -0.81 -2.82 -4.38 0.00 -14.08 -1.23 -1.90
% of Revenue 4.20 4.19 3.90 4.10 4.00 4.03 4.07 4.02 3.93 4.12 4.04 3.90 3.80 3.74 3.63 3.51 3.51 3.05 3.04 3.00
Interest Expense -3,063 -3,413 -3,206 -3,520 -3,943 -3,745 -3,800 -3,753 -3,570 -3,509 -3,380 -3,367 -3,284 -2,946 -3,021 -2,647 -2,959 -2,724 -2,648 -2,514
Change (%) 11.41 -6.06 9.78 12.02 -5.02 1.46 -1.24 -4.88 -1.69 -3.69 -0.39 -2.46 -10.30 2.56 -12.39 11.78 -7.92 -2.81 -5.05
% of Revenue -0.70 -0.75 -0.68 -0.70 -0.77 -0.72 -0.72 -0.70 -0.65 -0.64 -0.59 -0.57 -0.56 -0.49 -0.50 -0.45 -0.50 -0.47 -0.46 -0.44
Net Income 6,616 7,187 6,956 7,874 7,930 7,759 7,970 7,870 7,914 8,526 8,688 8,936 8,765 9,054 8,884 8,646 8,327 7,050 7,087 6,811
Change (%) 8.64 -3.22 13.21 0.71 -2.16 2.73 -1.26 0.57 7.72 1.91 2.86 -1.92 3.29 -1.88 -2.67 -3.69 -15.34 0.52 -3.89
% of Revenue 1.50 1.57 1.46 1.57 1.55 1.49 1.51 1.48 1.45 1.54 1.52 1.51 1.48 1.52 1.48 1.46 1.41 1.21 1.22 1.18

Source: Capital IQ

Other Listings
US:SHTDY
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista